As Executive Vice President at EMMES, Dr. Lindblad serves the company with more than 20 years of combined experience in biostatistics, clinical design, and project management.

Dr. Lindblad holds a Ph.D. in statistics from the George Washington University, and a master's in biostatistics from the Medical College of Virginia. She is the author or co-author of more than 100 publications and oral presentations. Her professional leadership ability is illustrated as a member or chair of Data and Safety Monitoring Committees for the National Eye Institute (NEI) and for the National Institute on Alcohol Abuse and Alcoholism. Dr. Lindblad has been, and currently is, a reviewer of NIH grant and contract applications from multiple NIH Institutes. She has served as an elected member of the Board of Directors for the Society for Clinical Trials, and as the Program Chair for that organization.

Dr. Lindblad has been the Coordinating Center PrincipaI Investigator for major NEI efforts including large, multi-center Phase III clinical trials and NEI intramural Phase I and II trials. She has led an industry-sponsored pediatric liver transplantation registry and a multi-protocol statistical and data coordinating center program for the National Institute on Deafness and Other Communication Disorders. She also provides corporate oversight for both industry- and government-sponsored projects within the company.

Dr. Lindblad contributes to the successful execution of The EMMES Corporation's activities through her expertise and experience in clinical trials and through the active promotion of effective liaisons with sponsors and study participants.

Dr. Lindblad serves as a member on the National Advisory Dental and Craniofacial Research Council of the National Institute of Dental and Craniofacial Research until December 2008.